In vivo Diagnosis of Primary Cutaneous Amyloidosis -the Role of Reflectance Confocal Microscopy.
cutaneous amyloidosis
in vivo
non-invasive
reflectance confocal microscopy
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
27 Jun 2019
27 Jun 2019
Historique:
received:
17
05
2019
revised:
20
06
2019
accepted:
24
06
2019
entrez:
30
6
2019
pubmed:
30
6
2019
medline:
30
6
2019
Statut:
epublish
Résumé
Primary cutaneous amyloidosis (PCA) is a form of localized amyloidosis. It is characterized by the deposition of a fibrillar material in the superficial dermis, without affecting other systems or organs. The diagnosis can be made clinically, but usually a skin biopsy is performed in order to exclude other skin diseases with similar appearance. Reflectance confocal microscopy (RCM) is a novel imaging tool that enables in vivo characterization of various skin changes with a high, quasi-microscopic resolution. This technique might have an important role in the differential diagnosis of cutaneous amyloidosis, by the in vivo assessment of epidermal changes and dermal amyloid deposition. Moreover, it is completely non-invasive and can be safely repeated on the same skin area. However, to date, there is only one published paper presenting the confocal features of primary cutaneous amyloidosis. Hereby, we describe the in vivo RCM features of PCA lesions from a patient with diabetes and correlate them with histologic findings. This strengthens the clinical usefulness of in vivo RCM examination for the non-invasive diagnosis of cutaneous amyloidosis, especially in patients that might associate diseases with impaired wound healing.
Identifiants
pubmed: 31252549
pii: diagnostics9030066
doi: 10.3390/diagnostics9030066
pmc: PMC6787715
pii:
doi:
Types de publication
Case Reports
Langues
eng
Subventions
Organisme : Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii
ID : project no. 61PCCDI⁄2018 PN-III-P1-1.2-PCCDI-2017-0341
Références
Exp Ther Med. 2018 Feb;15(2):1241-1246
pubmed: 29434710
Exp Ther Med. 2019 Feb;17(2):1052-1060
pubmed: 30679973
Eur J Dermatol. 2010 Mar-Apr;20(2):152-60
pubmed: 20071301
J Biomed Opt. 2012 Aug;17(8):085003
pubmed: 23224186
Int J Dermatol. 2004 Dec;43(12):898-9
pubmed: 15569011
Rom J Morphol Embryol. 2014;55(3 Suppl):1191-6
pubmed: 25607405
Int J Clin Pract. 2005 Aug;59(8):983-5
pubmed: 16033625
Mol Clin Oncol. 2018 May;8(5):640-646
pubmed: 29725529
Skin Res Technol. 2017 Aug;23(3):441-443
pubmed: 28083882
Exp Ther Med. 2019 Feb;17(2):1004-1011
pubmed: 30679966
JAAD Case Rep. 2018 Nov 10;4(10):1014-1023
pubmed: 30456275
Rom J Morphol Embryol. 2014;55(4):1437-41
pubmed: 25611278
J Digit Imaging. 2010 Aug;23(4):475-81
pubmed: 19513794
G Ital Dermatol Venereol. 2015 Oct;150(5):547-63
pubmed: 26140397
J Clin Med. 2019 Apr 03;8(4):null
pubmed: 30987174
Br J Dermatol. 2011 Jan;164(1):148-53
pubmed: 21070198
Medicina (Kaunas). 2013;49(11):497-503
pubmed: 24823932
Exp Dermatol. 2009 Jun;18(6):536-40
pubmed: 19320740
Acta Med Iran. 2014;52(2):163-5
pubmed: 24659076
Clin Dermatol. 2003 Sep-Oct;21(5):359-69
pubmed: 14678715
J Dermatol Case Rep. 2008 Dec 27;2(4):55-9
pubmed: 21886715
PLoS One. 2015 Mar 23;10(3):e0120623
pubmed: 25799390
Oncol Lett. 2019 May;17(5):4102-4111
pubmed: 30944603
Oncol Lett. 2016 May;11(5):3019-3024
pubmed: 27123056
J Invest Dermatol. 2007 Dec;127(12):2759-65
pubmed: 17657243
Acta Dermatovenerol Croat. 2017 Oct;25(3):223-227
pubmed: 29252175
Int J Dermatol. 2010 Aug;49(8):960-2
pubmed: 21128925